42 Stocks Moving In Monday’s Mid-Day Session
Gainers
Mullen Automotive, Inc. (NASDAQ: MULN) jumped 74.4% to $1.20 after the company reported progress on solid-state polymer battery pack development.
Why Aurinia Pharmaceuticals Shares Are Falling Today
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is trading significantly lower Monday after the company reported declining fourth-quarter financial results on a year-over-year basis.
Aurinia Pharmaceuticals Q4 EPS $(0.25) Down From $(0.06) YoY, Sales $23.40M Down From $50.03M YoY
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly losses of $(0.25) per share. This is a 316.67 percent decrease over losses of $(0.06) per share from the same period last year. The company reported $23.40
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter.
RBC Capital Maintains Outperform on Aurinia Pharmaceuticals, Lowers Price Target to $31
RBC Capital analyst Douglas Miehm maintains Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Outperform and lowers the price target from $34 to $31.
Aurinia Pharma Shares Up 8.5% Following Earlier Co. Presentation At Leerink Global Healthcare Conference; Social Media Circulation Of Comment From Co. ‘Aggressive Numbers Will Come From Us’
https://twitter.com/RabunRaven/status/1493965199732314114https://twitter.com/RabunRaven/status/1493965199732314114
Expert Ratings For Aurinia Pharmaceuticals
Within the last quarter, Aurinia Pharmaceuticals (NASDAQ:AUPH) has observed the following analyst ratings:
Oppenheimer Upgrades Aurinia Pharmaceuticals to Outperform, Lowers Price Target to $31
Oppenheimer analyst Justin Kim upgrades Aurinia Pharmaceuticals (NASDAQ:AUPH) from Perform to Outperform and lowers the price target from $33 to $31.